DUBLIN--(BUSINESS WIRE)--The "Oesophageal Cancer Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.
Oesophageal Cancer Pipeline Highlights - 2017 Update, provides most up-to-date information on key pipeline products in the global Oesophageal Cancer market.
It covers emerging therapies for Oesophageal Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Oesophageal Cancer pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Oesophageal Cancer pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Oesophageal Cancer pipeline products by the company.
Short-term Launch Highlights:
Find out which Oesophageal Cancer pipeline products will be launched in the US and Ex-US till 2020.
Key Topics Covered:
1. Oesophageal Cancer Pipeline by Stages
2. Oesophageal Cancer Pipeline by Drug Class
3. Oesophageal Cancer Pipeline by Company
4. Oesophageal Cancer Phase 3 Clinical Trial Insights
5. Oesophageal Cancer Phase 2 Clinical Trial Insights
6. Oesophageal Cancer Phase 1 Clinical Trial Insights
7. Oesophageal Cancer Preclinical Research Insights
8. Oesophageal Cancer Discovery Stage Insights
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/ld9nr9/global?w=4